RDNT
RadNet, Inc.NASDAQHealthcare$54.79-0.94%ClosedMarket Cap: $4.25B
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
3.78
P/S
2.08
EV/EBITDA
21.04
DCF Value
$-37.12
FCF Yield
-4.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
11.2%
Operating Margin
3.0%
Net Margin
-0.9%
ROE
-1.9%
ROA
-0.7%
ROIC
1.0%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $547.7M | 12.6% | $27.8M | $-597.0K | $-0.01 | — |
| FY 2025 | $2.04B | 4.5% | $90.8M | $-18.7M | $-0.25 | — |
| Q3 2025 | $522.9M | 13.9% | $27.4M | $5.4M | $0.07 | — |
| Q2 2025 | $498.2M | 13.9% | $30.9M | $14.5M | $0.19 | — |
| Q1 2025 | $471.4M | 3.8% | $-24.1M | $-37.9M | $-0.51 | — |
| Q4 2024 | $477.1M | 13.8% | $24.5M | $5.3M | $0.07 | — |
| FY 2024 | $1.83B | 13.6% | $104.6M | $2.8M | $0.04 | — |
| Q3 2024 | $461.1M | 15.0% | $33.9M | $3.2M | $0.04 | — |
| Q2 2024 | $459.7M | 15.2% | $34.8M | $-3.0M | $-0.04 | — |
| Q1 2024 | $431.7M | 10.2% | $11.3M | $-2.8M | $-0.04 | — |
| Q4 2023 | $420.4M | 15.2% | $24.3M | $-1.9M | $-0.03 | — |
| FY 2023 | $1.62B | 13.7% | $98.7M | $3.0M | $0.05 | — |